ÂÜÀòÂÒÂ×

Keith Orford serves as the Chief Medical Officer at Parabilis Medicines since November 2021, contributing extensive experience in clinical development and translational science. Previously, Keith held leadership roles at Calithera Biosciences from January 2015 to 2023, and at GSK as the Clinical Development Lead for the Immuno-Oncology and Combinations Discovery Performance Unit from December 2010 to January 2015. Other past positions include Director of Clinical Development in Oncology at Merck and various roles at Massachusetts General Hospital. Keith holds an MD/PhD in Medicine and Cell Biology from Georgetown University School of Medicine, as well as a Bachelor's degree from Georgetown University.